NASDAQ:DMTK (DermTech)

About DMTK

DermTech Inc is an emerging growth molecular diagnostic company. The company is engaged in marketing and developing novel non-invasive genomic tests to aid in the diagnosis of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. While the company generates revenue through laboratory services.
  • DermTech (NASDAQ: DMTK) Latest News

    No posts found.